-
What Would A $5.8 Billion NIH Cut Look Like? Devastation
Thursday, April 20, 2017 - 1:38pm | 1882Read More...Neither Republicans nor Democrats are eager to cut the National Institutes of Health funding by the president’s suggested $5.8 billion, but with the proposal still on the table, the sum is not yet safe. And as 18 percent of the current $31.7 billion budget hangs in the balance, more Americans...
-
Napodano: Nuvo Research Spin-Out Should Unlock Value For Investors
Thursday, October 1, 2015 - 12:48pm | 4819Read More...On September 15, 2015, Nuvo Research, Inc. (NRI.TO) (NRIFF) announced that it plans to split into two separately traded public companies, with a goal of enhancing long-term value for Nuvo shareholders. The strategy will be to separate the pure-play commercial organization that includes a...
-
Biotech Expert Talks Potential M&A Activity, Partnerships And Women's Health
Tuesday, August 25, 2015 - 2:59pm | 401Read More...Benzinga recently had the chance to chat with Jason Napodano, biopharma analyst and consultant, owner of BioNap Consulting and former biotech analyst at Zacks. Below are just a few of the expert’s comments on potential M&A activity and partnerships in the biotech segment in the current...
-
What Should Biotech Investors Do Now?
Tuesday, August 25, 2015 - 2:47pm | 472Read More...Benzinga recently had the chance to talk with Jason Napodano, biopharma analyst and consultant, and owner of BioNap Consulting. Below is a look at some highlights from the expert. Macro Conditions And The Biotech Industry When asked about the current state of macro conditions for the biotech...
